Literature DB >> 117878

Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.

S Madsbad, K G Alberti, C Binder, J M Burrin, O K Faber, T Krarup, L Regeur.   

Abstract

The role of preserved beta-cell function in preventing ketoacidosis in type I insulin-dependent diabetes was assessed in eight patients with and seven patients without residual beta-cell function as determined from C-peptide concentrations. After 12 hours of insulin fatty-acid, and glycerol concentrations were all significantly higher in patients without beta-cell function than in those with residual secretion. Mean blood glucose concentrations reached 17.2 +/- SE of mean 1.3 mmol/l (310 +/- 23 mg/100 ml) in the first group compared with 8.8 +/- 1.4 mmol/l (159 +/- 25 mg/100 ml) in the second (P less than 0.01), while 3-hydroxybutyrate concentrations rose to 5.5 +/- mmol/l (57 +/- 5 mg/100 ml) and 1.4 +/- 0.3 mmol/l (15 +/- 3 mg/100 ml) in the two groups respectively (P less than 0.01). Individual mean C-peptide concentrations showed a significant inverse correlation with the final blood glucose values (r = -0.91; P less than 0.02). These findings strongly suggest that even minimal residual insulin secretion is important for metabolic wellbeing in diabetes and may prevent the development of severe ketoacidosis when insulin delivery is inadequate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117878      PMCID: PMC1596922          DOI: 10.1136/bmj.2.6200.1257

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve.

Authors:  K Shima; R Tanaka; S Morishita; S Tarui; Y Kumahara
Journal:  Diabetes       Date:  1977-08       Impact factor: 9.461

2.  A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay.

Authors:  R J Ho; H C Meng
Journal:  Anal Biochem       Date:  1969-10-01       Impact factor: 3.365

3.  C-peptide in children with juvenile diabetes. A preliminary report.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

4.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

Authors:  J E Gerich; M Lorenzi; D M Bier; V Schneider; E Tsalikian; J H Karam; P H Forsham
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

5.  Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.

Authors:  S Madsbad; O K Faber; C Binder; P McNair; C Christiansen; I Transbøl
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin.

Authors:  O K Faber; J Markussen; V K Naithani; C Binder
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-06

7.  Ketoacidosis in pancreatectomized man.

Authors:  A J Barnes; S R Bloom; K Goerge; G M Alberti; P Smythe; F P Alford; D J Chisholm
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

8.  Role of glucagon and other hormones in development of diabetic ketoacidosis.

Authors:  K G Alberti
Journal:  Lancet       Date:  1975-06-14       Impact factor: 79.321

  8 in total
  39 in total

1.  Immune intervention in children with type 1 diabetes.

Authors:  Johnny Ludvigsson
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

2.  Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1.

Authors:  Ofer Yanay; Daniel Moralejo; Kelly Kernan; Margaret Brzezinski; Jessica M Fuller; Randall W Barton; Ake Lernmark; William R Osborne
Journal:  J Gene Med       Date:  2010-06       Impact factor: 4.565

3.  Guidelines on the use of extracorporeal photopheresis.

Authors:  R Knobler; G Berlin; P Calzavara-Pinton; H Greinix; P Jaksch; L Laroche; J Ludvigsson; P Quaglino; W Reinisch; J Scarisbrick; T Schwarz; P Wolf; P Arenberger; C Assaf; M Bagot; M Barr; A Bohbot; L Bruckner-Tuderman; B Dreno; A Enk; L French; R Gniadecki; H Gollnick; M Hertl; C Jantschitsch; A Jung; U Just; C-D Klemke; U Lippert; T Luger; E Papadavid; H Pehamberger; A Ranki; R Stadler; W Sterry; I H Wolf; M Worm; J Zic; C C Zouboulis; U Hillen
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-01       Impact factor: 6.166

Review 4.  Mesenchymal stromal cells to halt the progression of type 1 diabetes?

Authors:  Per-Ola Carlsson; Olle Korsgren; Katarina Le Blanc
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

5.  Control of glycolysis in rat liver by glucokinase and phosphofructokinase: influence of glucose concentration.

Authors:  N V Torres; F Mateo; J M Riol-Cimas; E Meléndez-Hevia
Journal:  Mol Cell Biochem       Date:  1990-03-05       Impact factor: 3.396

6.  [Severe atypical ketoacidosis due to SGLT2-inhibitor therapy : Two case reports].

Authors:  T G K Breuer; K Kampmann; A Wutzler; C Steinfort; W Uhl; W E Schmidt; J J Meier
Journal:  Internist (Berl)       Date:  2018-03       Impact factor: 0.743

7.  The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.

Authors:  A J Francis; I Hanning; K G Alberti
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

8.  Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.

Authors:  J C Pickup; G C Viberti; R W Bilous; H Keen; K G Alberti; P D Home; C Binder
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

Review 9.  Management of newly diagnosed diabetes: home or hospital?

Authors:  L Lowes; J W Gregory
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

10.  Preservation of beta-cell function in autoantibody-positive youth with diabetes.

Authors:  Carla J Greenbaum; Andrea M Anderson; Lawrence M Dolan; Elizabeth J Mayer-Davis; Dana Dabelea; Giuseppina Imperatore; Santica Marcovina; Catherine Pihoker
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.